Emanuela Palmerini


Ontology type: schema:Person     


Person Info

NAME

Emanuela

SURNAME

Palmerini

Publications in SciGraph latest 50 shown

  • 2022-06-08 Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial) in BMC CANCER
  • 2021-07-08 18F-FDG PET in Treatment Response Evaluation: Soft Tissue Sarcomas in ATLAS OF CLINICAL PET-CT IN TREATMENT RESPONSE EVALUATION IN ONCOLOGY
  • 2021-07-02 Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry in ORPHANET JOURNAL OF RARE DISEASES
  • 2021-04-29 The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study in ORPHANET JOURNAL OF RARE DISEASES
  • 2021-02-12 Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2021-01-22 Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab in BMC CANCER
  • 2020-07-04 Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2020-07-02 Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) in SCIENTIFIC REPORTS
  • 2020-06-22 Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group in ANNALS OF SURGICAL ONCOLOGY
  • 2019-12-07 Chemotherapy of Soft Tissue Sarcomas in DIAGNOSIS OF MUSCULOSKELETAL TUMORS AND TUMOR-LIKE CONDITIONS
  • 2019-12-07 Chemotherapy of Ewing Sarcoma in DIAGNOSIS OF MUSCULOSKELETAL TUMORS AND TUMOR-LIKE CONDITIONS
  • 2019-12-07 Chemotherapy of Osteosarcoma in DIAGNOSIS OF MUSCULOSKELETAL TUMORS AND TUMOR-LIKE CONDITIONS
  • 2018-01-15 Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma in BONE MARROW TRANSPLANTATION
  • 2017-05-03 Erratum to: Osteosarcoma follow-up: chest X-ray or computed tomography? in CLINICAL SARCOMA RESEARCH
  • 2017-04-12 The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-02-14 Osteosarcoma follow-up: chest X-ray or computed tomography? in CLINICAL SARCOMA RESEARCH
  • 2016-09-20 The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-04-20 Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone in BMC CANCER
  • 2015-10-29 High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma? in CLINICAL SARCOMA RESEARCH
  • 2015-06-30 MRgFUS new applications in musculoskeletal pathology: a miscellaneous case review in JOURNAL OF THERAPEUTIC ULTRASOUND
  • 2015-01-23 Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? in ORPHANET JOURNAL OF RARE DISEASES
  • 2014-05-03 State-of-the-art approach for bone sarcomas in EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY & TRAUMATOLOGY
  • 2012-08-09 Palliative embolisation for advanced bone sarcomas in LA RADIOLOGIA MEDICA
  • 2012-01-27 Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans in CLINICAL SARCOMA RESEARCH
  • 2011-10 Nuove frontiere nel trattamento del tumore a cellule giganti dell’osso in LO SCALPELLO-OTODI EDUCATIONAL
  • 2009-08-12 The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future in PEDIATRIC AND ADOLESCENT OSTEOSARCOMA
  • 2006-04-28 Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors in JOURNAL OF NEURO-ONCOLOGY
  • 2005-07 Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis in JOURNAL OF NEURO-ONCOLOGY
  • 2004-08-10 Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.419038.7", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413396.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413990.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415778.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476460.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419555.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412311.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415207.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414405.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411457.2", 
            "type": "Organization"
          }
        ], 
        "familyName": "Palmerini", 
        "givenName": "Emanuela", 
        "id": "sg:person.01210215667.35", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-3406-6705"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35", 
          "https://orcid.org/0000-0003-3406-6705"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_695.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01210215667.35'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01210215667.35'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01210215667.35'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01210215667.35'


     

    This table displays all metadata directly associated to this object as RDF triples.

    47 TRIPLES      11 PREDICATES      26 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01210215667.35 schema:affiliation Ncfc6a86685f94abc8c97e359110b0391
    2 grid-institutes:grid.14925.3b
    3 grid-institutes:grid.411457.2
    4 grid-institutes:grid.412311.4
    5 grid-institutes:grid.413396.a
    6 grid-institutes:grid.413990.6
    7 grid-institutes:grid.414405.0
    8 grid-institutes:grid.415207.5
    9 grid-institutes:grid.415778.8
    10 grid-institutes:grid.417893.0
    11 grid-institutes:grid.419555.9
    12 grid-institutes:grid.476460.7
    13 grid-institutes:grid.51462.34
    14 grid-institutes:grid.6292.f
    15 schema:familyName Palmerini
    16 schema:givenName Emanuela
    17 schema:identifier N6320482b5784499c8b3039044b89abf2
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
    19 https://orcid.org/0000-0003-3406-6705
    20 schema:sdDatePublished 2022-08-04T17:38
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher Nede0d9c368b7433fa1d6c627576335dd
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N6320482b5784499c8b3039044b89abf2 schema:name orcid_id
    27 schema:value 0000-0003-3406-6705
    28 rdf:type schema:PropertyValue
    29 Ncfc6a86685f94abc8c97e359110b0391 schema:affiliation grid-institutes:grid.419038.7
    30 sgo:isCurrent true
    31 rdf:type schema:OrganizationRole
    32 Nede0d9c368b7433fa1d6c627576335dd schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 grid-institutes:grid.14925.3b schema:Organization
    35 grid-institutes:grid.411457.2 schema:Organization
    36 grid-institutes:grid.412311.4 schema:Organization
    37 grid-institutes:grid.413396.a schema:Organization
    38 grid-institutes:grid.413990.6 schema:Organization
    39 grid-institutes:grid.414405.0 schema:Organization
    40 grid-institutes:grid.415207.5 schema:Organization
    41 grid-institutes:grid.415778.8 schema:Organization
    42 grid-institutes:grid.417893.0 schema:Organization
    43 grid-institutes:grid.419038.7 schema:Organization
    44 grid-institutes:grid.419555.9 schema:Organization
    45 grid-institutes:grid.476460.7 schema:Organization
    46 grid-institutes:grid.51462.34 schema:Organization
    47 grid-institutes:grid.6292.f schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...